1
An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:April 11, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Hemophilia ALast Updated:April 11, 2022Completed
Condition(s):Severe Hemophilia ALast Updated:December 19, 2020Completed
Condition(s):Hemophilia ALast Updated:December 19, 2020Completed
Condition(s):Severe Hemophilia ALast Updated:December 19, 2020Completed
Condition(s):Hemophilia A With InhibitorsLast Updated:March 28, 2022Completed
Condition(s):Hemophilia ALast Updated:December 19, 2020Completed
Condition(s):Hemophilia A; Hemophilia BLast Updated:December 19, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.